FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205526719> ?p ?o ?g. }

• W4205526719 abstract "Abstract Background Background incidence rates are critical in pharmacovigilance to facilitate identification of vaccine safety signals. We estimated background incidence rates of nine adverse events of special interest related to COVID-19 vaccines in Ontario, Canada. Methods We conducted a population-based retrospective observational study using linked health administrative databases for hospitalizations and emergency department visits among Ontario residents. We estimated incidence rates of Bell’s palsy, idiopathic thrombocytopenia, febrile convulsions, acute disseminated encephalomyelitis, myocarditis, pericarditis, Kawasaki disease, Guillain-Barré syndrome, and transverse myelitis during five pre-pandemic years (2015– 2019) and 2020. Results The average annual population was 14 million across all age groups with 51% female. The pre-pandemic mean annual rates per 100,000 population during 2015–2019 were 43.9 for idiopathic thrombocytopenia, 27.8 for Bell’s palsy, 25.0 for febrile convulsions, 22.8 for acute disseminated encephalomyelitis, 11.3 for myocarditis/pericarditis, 8.6 for pericarditis, 2.9 for myocarditis, 1.9 for Guillain-Barré syndrome, 1.7 for transverse myelitis, and 1.6 for Kawasaki disease. Females had higher rates of acute disseminated encephalomyelitis and transverse myelitis while males had higher rates of myocarditis, pericarditis, and Guillain-Barré syndrome. Bell’s palsy, acute disseminated encephalomyelitis, and Guillain-Barré syndrome increased with age. The mean rates of myocarditis and/or pericarditis increased with age up to 79 years; males had higher rates than females: from 12–59 years for myocarditis and ≥12 years for pericarditis. Febrile convulsions and Kawasaki disease were predominantly childhood diseases and generally decreased with age. Conclusions Our estimated background rates will permit estimating numbers of expected events for these conditions and facilitate detection of potential safety signals following COVID-19 vaccination." @default.
• W4205526719 created "2022-01-25" @default.
• W4205526719 creator A5010239092 @default.
• W4205526719 creator A5037169534 @default.
• W4205526719 creator A5037445975 @default.
• W4205526719 creator A5055270548 @default.
• W4205526719 creator A5073405050 @default.
• W4205526719 creator A5078064190 @default.
• W4205526719 creator A5090747112 @default.
• W4205526719 date "2022-01-16" @default.
• W4205526719 modified "2023-09-25" @default.
• W4205526719 title "Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance" @default.
• W4205526719 cites W2023346384 @default.
• W4205526719 cites W2031526334 @default.
• W4205526719 cites W2041104116 @default.
• W4205526719 cites W2044319758 @default.
• W4205526719 cites W2109552032 @default.
• W4205526719 cites W2117671584 @default.
• W4205526719 cites W2119169318 @default.
• W4205526719 cites W2132071829 @default.
• W4205526719 cites W2909280755 @default.
• W4205526719 cites W3134987890 @default.
• W4205526719 cites W3138582961 @default.
• W4205526719 cites W3159001141 @default.
• W4205526719 cites W3160661236 @default.
• W4205526719 cites W3165142255 @default.
• W4205526719 cites W3166109011 @default.
• W4205526719 cites W3169253227 @default.
• W4205526719 cites W4200093360 @default.
• W4205526719 cites W4200242237 @default.
• W4205526719 cites W4211233178 @default.
• W4205526719 cites W4244302965 @default.
• W4205526719 cites W4281554604 @default.
• W4205526719 doi "https://doi.org/10.1101/2022.01.12.22269169" @default.
• W4205526719 hasPublicationYear "2022" @default.
• W4205526719 type Work @default.
• W4205526719 citedByCount "2" @default.
• W4205526719 countsByYear W42055267192022 @default.
• W4205526719 countsByYear W42055267192023 @default.
• W4205526719 crossrefType "posted-content" @default.
• W4205526719 hasAuthorship W4205526719A5010239092 @default.
• W4205526719 hasAuthorship W4205526719A5037169534 @default.
• W4205526719 hasAuthorship W4205526719A5037445975 @default.
• W4205526719 hasAuthorship W4205526719A5055270548 @default.
• W4205526719 hasAuthorship W4205526719A5073405050 @default.
• W4205526719 hasAuthorship W4205526719A5078064190 @default.
• W4205526719 hasAuthorship W4205526719A5090747112 @default.
• W4205526719 hasBestOaLocation W42055267191 @default.
• W4205526719 hasConcept C120665830 @default.
• W4205526719 hasConcept C121332964 @default.
• W4205526719 hasConcept C126322002 @default.
• W4205526719 hasConcept C187212893 @default.
• W4205526719 hasConcept C203014093 @default.
• W4205526719 hasConcept C2776820930 @default.
• W4205526719 hasConcept C2777185649 @default.
• W4205526719 hasConcept C2778691916 @default.
• W4205526719 hasConcept C2779134260 @default.
• W4205526719 hasConcept C2779328510 @default.
• W4205526719 hasConcept C2780640218 @default.
• W4205526719 hasConcept C2780875844 @default.
• W4205526719 hasConcept C2781001862 @default.
• W4205526719 hasConcept C2781026528 @default.
• W4205526719 hasConcept C2781304901 @default.
• W4205526719 hasConcept C2781423770 @default.
• W4205526719 hasConcept C2908647359 @default.
• W4205526719 hasConcept C61511704 @default.
• W4205526719 hasConcept C71924100 @default.
• W4205526719 hasConcept C99454951 @default.
• W4205526719 hasConceptScore W4205526719C120665830 @default.
• W4205526719 hasConceptScore W4205526719C121332964 @default.
• W4205526719 hasConceptScore W4205526719C126322002 @default.
• W4205526719 hasConceptScore W4205526719C187212893 @default.
• W4205526719 hasConceptScore W4205526719C203014093 @default.
• W4205526719 hasConceptScore W4205526719C2776820930 @default.
• W4205526719 hasConceptScore W4205526719C2777185649 @default.
• W4205526719 hasConceptScore W4205526719C2778691916 @default.
• W4205526719 hasConceptScore W4205526719C2779134260 @default.
• W4205526719 hasConceptScore W4205526719C2779328510 @default.
• W4205526719 hasConceptScore W4205526719C2780640218 @default.
• W4205526719 hasConceptScore W4205526719C2780875844 @default.
• W4205526719 hasConceptScore W4205526719C2781001862 @default.
• W4205526719 hasConceptScore W4205526719C2781026528 @default.
• W4205526719 hasConceptScore W4205526719C2781304901 @default.
• W4205526719 hasConceptScore W4205526719C2781423770 @default.
• W4205526719 hasConceptScore W4205526719C2908647359 @default.
• W4205526719 hasConceptScore W4205526719C61511704 @default.
• W4205526719 hasConceptScore W4205526719C71924100 @default.
• W4205526719 hasConceptScore W4205526719C99454951 @default.
• W4205526719 hasLocation W42055267191 @default.
• W4205526719 hasOpenAccess W4205526719 @default.
• W4205526719 hasPrimaryLocation W42055267191 @default.
• W4205526719 hasRelatedWork W1978256344 @default.
• W4205526719 hasRelatedWork W1981121264 @default.
• W4205526719 hasRelatedWork W1987115587 @default.
• W4205526719 hasRelatedWork W2093569029 @default.
• W4205526719 hasRelatedWork W2405422890 @default.
• W4205526719 hasRelatedWork W2416832108 @default.
• W4205526719 hasRelatedWork W4205526719 @default.
• W4205526719 hasRelatedWork W4210243865 @default.
• W4205526719 hasRelatedWork W4226315319 @default.

• next